先声药业(02096)1月16日斥资5163.28万港元回购443.3万股
SIMCERE PHARMASIMCERE PHARMA(HK:02096) 智通财经网·2026-01-16 10:43

Core Viewpoint - The company, Sihon Pharmaceutical (02096), announced a share buyback plan, indicating a strategic move to enhance shareholder value by repurchasing shares at a significant cost [1] Group 1: Company Actions - The company will spend HKD 51.6328 million to repurchase 4.433 million shares [1]